biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.
Company profile
Ticker
BSGM
Exchange
Website
CEO
Kenneth L. Londoner
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
SEC CIK
Corporate docs
Subsidiaries
ViralClear Pharmaceuticals, Inc. • NeuroClear Technologies, Inc. ...
BSGM stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Mar 24
8-K
Entry into a Material Definitive Agreement
12 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Mar 24
8-K
Departure of Directors or Certain Officers
28 Feb 24
8-K
Departure of Directors or Certain Officers
21 Feb 24
8-K
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
6 Feb 24
8-K/A
Cost Associated with Exit or Disposal Activities
2 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
1 Feb 24
Latest ownership filings
144
Notice of proposed sale of securities
11 Mar 24
4
Frederick Hrkac
4 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Frederick Hrkac
4 Jan 24
4/A
John Sieckhaus
5 Dec 23
4/A
Gray Fleming
5 Dec 23
4
John Sieckhaus
4 Dec 23
4
Gray Fleming
4 Dec 23
4
KENNETH L LONDONER
4 Dec 23
4
IV David Weild
18 Aug 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 389.00 k | 389.00 k | 389.00 k | 389.00 k | 389.00 k | 389.00 k |
Cash burn (monthly) | 287.67 k | 41.50 k | 1.35 mm | 2.46 mm | 1.28 mm | 1.54 mm |
Cash used (since last report) | 1.91 mm | 276.04 k | 8.98 mm | 16.39 mm | 8.49 mm | 10.25 mm |
Cash remaining | -1.52 mm | 112.96 k | -8.59 mm | -16.00 mm | -8.10 mm | -9.86 mm |
Runway (months of cash) | -5.3 | 2.7 | -6.4 | -6.5 | -6.3 | -6.4 |
Institutional ownership, Q2 2023
7.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 56 |
Opened positions | 12 |
Closed positions | 6 |
Increased positions | 11 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 6.54 bn |
Total shares | 6.40 mm |
Total puts | 100.00 |
Total calls | 197.20 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 1.65 mm | $2.07 bn |
Cherry David | 1.03 mm | $0.00 |
Advisor Resource Council | 901.21 k | $1.13 bn |
BLK Blackrock | 594.16 k | $742.70 mm |
Geode Capital Management | 565.74 k | $707.17 mm |
Smith, Moore & Co. | 137.18 k | $171.47 mm |
Commonwealth Equity Services | 125.71 k | $157.00 k |
TFC Truist Financial | 112.27 k | $140.34 mm |
NTRS Northern Trust | 110.86 k | $138.57 mm |
STT State Street | 108.07 k | $135.09 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | Frederick Hrkac | Common Stock | Grant | Acquire A | No | No | 0 | 500,000 | 0.00 | 509,501 |
28 Dec 23 | Frederick Hrkac | RSU Common Stock | Grant | Acquire A | No | No | 0 | 900,000 | 0.00 | 900,000 |
28 Dec 23 | Frederick Hrkac | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4742 | 600,000 | 284.52 k | 600,000 |
30 Nov 23 | Londoner Kenneth L | Common Stock | Grant | Acquire A | No | No | 0 | 219,700 | 0.00 | 2,726,720 |
30 Nov 23 | Gray Fleming | Stock Option Common Stock | Grant | Acquire A | No | No | 0.2603 | 131,900 | 34.33 k | 131,900 |
30 Nov 23 | John Sieckhaus | Stock Option Common Stock | Grant | Acquire A | No | No | 0.2603 | 92,300 | 24.03 k | 92,300 |
News
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
16 Apr 24
12 Health Care Stocks Moving In Tuesday's Intraday Session
16 Apr 24
12 Health Care Stocks Moving In Monday's Intraday Session
15 Apr 24
12 Health Care Stocks Moving In Friday's Intraday Session
12 Apr 24
12 Health Care Stocks Moving In Thursday's Intraday Session
11 Apr 24